Dabrafenib and trametinib targeted therapy
Dabrafenib (Dabrafenib) and trametinib (Trametinib) are two targeted drugs commonly used in cancer treatment, especially playing an important role in the treatment of malignant melanoma (MM). These two drugs are often used in combination to exert a synergistic effect and improve the efficacy of treatment.
First, dabrafenib is a BRAFkinase inhibitor that targets the BRAF V600 gene mutation, which occurs frequently in a variety of cancers, especially melanoma. It blocks the abnormal activation of the BRAF/MEK/ERK signaling pathway by inhibiting the activity of BRAF kinase, thereby inhibiting the growth and division of tumor cells.

Trametinib is a MEKkinase inhibitor that acts on MEKkinase in the signaling pathway. Through combined application with dabrafenib, trametinib can block the signal transduction pathway more comprehensively and slow down or prevent the proliferation and spread of cancer cells, thereby achieving more effective therapeutic effects.
The combination of these two drugs resulted in significant clinical benefit for melanoma patients withBRAF V600E/Kmutations. Studies have shown that this combination therapy significantly improves patients' progression-free survival and overall survival, making the treatment effect more durable.
However, patients receiving these medications need to be closely monitored and aware of potential side effects, such as fever, skin lesions, hypertension, etc. The doctor will make adjustments and management according to the patient's specific situation to ensure that the patient gets the best treatment effect.
Dabrafenib is already on the market in China and has been included in medical insurance. Patients can buy it domestically. The price is about 10,000 yuan in China. The price is still relatively expensive. Please consult the local hospital pharmacy for specific prices. Dabrafenib, which is relatively cheap abroad, is mainly a generic drug, mainly a Laotian generic drug. The price is about two to three thousand yuan, which is much cheaper than domestic drugs. The ingredients of foreign generic drugs and domestic original drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)